Such possible involvement of S1P1 has been reaffirmed with CYM5442, another S1P1 selective modulator and a functional antagonist of S1P1 [82], indicating that S1P receptor modulation, possibly S1P1 modulation, could dramatically attenuate neuroinflammatory responses of microglia in MS. Here, S1PR1 is linked to myeloid sarcoma.